Protagonist Therapeutics Inc - PTGX - stock price prediction, stock price target, analyst ratings from 12 analysts

Protagonist Therapeutics Inc has a share price target of US$ 117, revenue growth forecast of 983.0%, and profit growth estimate of 303.9% for FY26, based on top 12 analyst calls.